Anthem Biosciences Limited
ANTHEMPharmaceuticals
Founded in 2006, Anthem Biosciences Ltd provides integrated CRDMO services and specializes in manufacturing specialty ingredients, focusing on both New Chemical Entities and New Biological Entities, with platforms like RNA interference and Antibody-Drug Conjugates.
What Anthem files
- Others29
- Investor Meet18
- Updates11
- Important6
- PPTs5
- Board Meeting4
Showing Results announcements (1)Clear filter
02-07-2026 · 06:34 pm
Anthem Biosciences clarified FY26 results. The reported PAT of INR 591.79 Cr was consistent across filings. Consolidated EPS omission in XBRL was a clerical error, not impacting other financials. A revised XBRL filing is being submitted.